Urinary BLACAT1 as a non-invasive biomarker for bladder cancer.
Fathia Z El SharkawiMahmoud El SabahHanaa B AtyaHussein M KhaledPublished in: Molecular biology reports (2023)
Upregulation of BLACAT1 in invasive stages predicted an unfavorable prognosis for patients with BCs, as it contributes to the migration and metastasis of BCs. Therefore, we can conclude that urinary BLACAT1 may be considered a non-invasive promising metastatic biomarker for BCs.